ATE334676T1 - Photo-empfindlichkeit-erhöhende conjugate zur targeting von pathogene - Google Patents

Photo-empfindlichkeit-erhöhende conjugate zur targeting von pathogene

Info

Publication number
ATE334676T1
ATE334676T1 AT98908829T AT98908829T ATE334676T1 AT E334676 T1 ATE334676 T1 AT E334676T1 AT 98908829 T AT98908829 T AT 98908829T AT 98908829 T AT98908829 T AT 98908829T AT E334676 T1 ATE334676 T1 AT E334676T1
Authority
AT
Austria
Prior art keywords
conjugates
pathogene
targeting
photo
sensitivity
Prior art date
Application number
AT98908829T
Other languages
English (en)
Inventor
Tayyaba Hasan
Michael R Hamblin
Nikos Soukos
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE334676T1 publication Critical patent/ATE334676T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98908829T 1997-03-06 1998-02-27 Photo-empfindlichkeit-erhöhende conjugate zur targeting von pathogene ATE334676T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/812,606 US6462070B1 (en) 1997-03-06 1997-03-06 Photosensitizer conjugates for pathogen targeting

Publications (1)

Publication Number Publication Date
ATE334676T1 true ATE334676T1 (de) 2006-08-15

Family

ID=25210103

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98908829T ATE334676T1 (de) 1997-03-06 1998-02-27 Photo-empfindlichkeit-erhöhende conjugate zur targeting von pathogene

Country Status (10)

Country Link
US (2) US6462070B1 (de)
EP (1) EP1017397B1 (de)
JP (1) JP2001513819A (de)
KR (1) KR20000076016A (de)
CN (1) CN1255063A (de)
AT (1) ATE334676T1 (de)
AU (1) AU737574B2 (de)
CA (1) CA2283868C (de)
DE (1) DE69835438T2 (de)
WO (1) WO1998039011A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462070B1 (en) * 1997-03-06 2002-10-08 The General Hospital Corporation Photosensitizer conjugates for pathogen targeting
DE19827417B4 (de) * 1998-06-19 2004-10-28 Hahn, Rainer, Dr.Med.Dent. Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen
US7015309B1 (en) 1999-06-23 2006-03-21 The Wistar Institute Of Anatomy And Biology Pyrrhocoricin-derived peptides, and methods of use thereof
US20020169107A1 (en) * 2001-01-19 2002-11-14 Mallinckrodt Inc. Novel aromatic azides for type I phototherapy
US7235685B2 (en) * 2001-07-03 2007-06-26 Mallinckrodt, Inc. Aromatic sulfenates for type I phototherapy
AU2795801A (en) * 2000-01-21 2001-07-31 Creighton University Biocidal molecules, macromolecular targets and methods of production and use
ES2356983T3 (es) * 2000-02-11 2011-04-15 The General Hospital Corporation Unión tisular fotoquímica.
US7090497B1 (en) * 2001-02-21 2006-08-15 Harris David M Method of periodontal laser treatment
GB0120022D0 (en) 2001-08-16 2001-10-10 Photobiotics Ltd Conjugate
US6558653B2 (en) * 2001-09-19 2003-05-06 Scot N. Andersen Methods for treating periodontal disease
US20040127892A1 (en) * 2002-01-31 2004-07-01 Harris David M. Periodontal laser and methods
NL1020336C2 (nl) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Toepassing van een verbinding voor de bereiding van een farmaceutisch preparaat voor het behandelen van brandwonden, en een werkwijze voor het behandelen van brandwonden.
US20040052798A1 (en) * 2002-09-12 2004-03-18 Ceramoptec Industries, Inc. Microbe reduction in the oral cavity with photosensitizers
BR0316245A (pt) * 2002-11-14 2005-10-04 Novartis Ag Atividade antimicrobiana de espécie de oxigênio reativo produtora de anticorpos
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
NL1022597C2 (nl) * 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
EP1781329B1 (de) * 2004-08-06 2013-07-31 Syneron Beauty Ltd. Therapievorrichtung
US20060047281A1 (en) 2004-09-01 2006-03-02 Syneron Medical Ltd. Method and system for invasive skin treatment
EA013327B1 (ru) 2005-08-24 2010-04-30 Иммуноджен, Инк. Способ приготовления очищенных конъюгатов лекарственных средств
EP1933941A2 (de) 2005-08-25 2008-06-25 Philip R. Houle Behandlungssysteme zur abgabe von sensibilisatorlösungen
AU2006315443A1 (en) * 2005-11-15 2007-05-24 The General Hospital Corporation Photoactivatable antimicrobial agents
CA2535276A1 (en) * 2006-02-06 2007-08-06 John Kennedy Therapy device and system and method for reducing harmful exposure to electromagnetic radiation
AU2006341380B2 (en) * 2006-03-31 2013-01-10 Emory University Light activated antiviral materials and devices and methods for decontaminating virus infected environments
EP2049105A4 (de) * 2006-07-27 2022-03-30 biolitec Unternehmensbeteiligungs II AG Antimikrobielle photodynamische therapie
US20090030257A1 (en) * 2007-07-25 2009-01-29 Ceramoptec Industries Inc. Anti-microbial photodynamic therapy
PL2244724T3 (pl) * 2008-01-07 2015-08-31 Rapid Pathogen Screening Inc Zastosowanie peptydów do poprawy gojenia się rany
US9115180B2 (en) 2008-01-07 2015-08-25 Rapid Pathogen Screening, Inc. Use of peptides for promoting wound healing
KR101626167B1 (ko) 2008-01-17 2016-05-31 시네론 메디컬 리미티드 개인용 모발 제거 장치 및 그 사용 방법
WO2009093230A2 (en) 2008-01-24 2009-07-30 Syneron Medical Ltd. A device, apparatus, and method of adipose tissue treatment
US9828622B2 (en) 2008-05-05 2017-11-28 The General Hospital Corporation Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same
US20100017750A1 (en) 2008-07-16 2010-01-21 Avner Rosenberg User interface
US9314293B2 (en) 2008-07-16 2016-04-19 Syneron Medical Ltd RF electrode for aesthetic and body shaping devices and method of using same
US8633311B2 (en) 2008-07-29 2014-01-21 Frontier Scientific, Inc. Topical application of porphyrins for killing or preventing the growth of bacteria or fungi on a mammal
US8859760B2 (en) 2008-07-29 2014-10-14 Frontier Scientific, Inc. Compositions for killing or preventing the growth of microbes
WO2010032235A1 (en) 2008-09-21 2010-03-25 Syneron Medical Ltd. A method and apparatus for personal skin treatment
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
ES2461619T3 (es) 2009-02-25 2014-05-20 Syneron Medical Ltd. Rejuvenecimiento eléctrico de la piel
EP3480202A1 (de) 2009-06-03 2019-05-08 ImmunoGen, Inc. Konjugationsverfahren
AU2010325682B2 (en) 2009-12-06 2014-09-11 Gilead Bar - Ilan A method and apparatus for personal skin treatment
RS58367B1 (sr) 2011-03-29 2019-03-29 Immunogen Inc Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
KR101385196B1 (ko) * 2012-05-17 2014-04-14 주식회사 유니크메디케어 광 조사를 이용한 광감각제―펩타이드를 유효성분으로 포함하는 발모 개선 또는 촉진용 조성물 및 이를 이용한 방법
US20130310327A1 (en) 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
US20160073634A1 (en) * 2012-06-22 2016-03-17 The General Hospital Corporation Beta-lactamase targeted photosensitizer for pesticide and pest detection
WO2014004680A1 (en) * 2012-06-26 2014-01-03 University Of Rochester Catheter/stent system for activation of photodynamic therapy within the catheter/stent system
MX359599B (es) 2012-10-04 2018-09-12 Immunogen Inc Uso de una membrana de pvdf para purificar conjugados de agentes de unión celular y agentes citotóxicos.
US9689111B2 (en) * 2013-03-14 2017-06-27 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Microwave initiation for deposition of porous organosilicate materials on fabrics
WO2014151756A1 (en) 2013-03-14 2014-09-25 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Microwave initiation for deposition of porous organosilicate materials on fabrics
ES2664411T3 (es) 2013-03-15 2018-04-19 Suncor Energy Inc. Composiciones herbicidas
EP3328491A4 (de) 2015-07-28 2019-05-01 PhotonMD, Inc. Systeme und verfahren zur lichttherapeutischen modulation von stickoxid
CN107648587A (zh) * 2017-10-23 2018-02-02 安徽科技学院 抗菌肽以及融合蛋白在制备治疗幽门螺旋杆菌病的药物中的应用
CN108588093A (zh) * 2018-04-11 2018-09-28 湖南文理学院 东方铃蟾肠道芽孢杆菌表达蛋白对泌乳奶牛粪便具有强除臭能力的ness1-a基因
JP7168770B2 (ja) * 2018-09-20 2022-11-09 エンビアル インコーポレイテッド ヘリコバクター・ピロリ認知用高分子複合体及びそれを含む光線力学治療用組成物
US11986666B2 (en) 2020-03-19 2024-05-21 Know Bio, Llc Illumination devices for inducing biological effects
US11147984B2 (en) 2020-03-19 2021-10-19 Know Bio, Llc Illumination devices for inducing biological effects
US11654294B2 (en) 2021-03-15 2023-05-23 Know Bio, Llc Intranasal illumination devices

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
DE3852304T3 (de) 1987-03-02 1999-07-01 Enzon Lab Inc Organismus als Träger für "Single Chain Antibody Domain (SCAD)".
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5198346A (en) 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5041078A (en) * 1989-03-06 1991-08-20 Baylor Research Foundation, A Nonprofit Corporation Of The State Of Texas Photodynamic viral deactivation with sapphyrins
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
AU1424492A (en) * 1991-02-20 1992-09-15 Christopher Capelli Non-protein intracellular receptor binding conjugates and a method of use thereof
US5486503A (en) 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
US6462070B1 (en) * 1997-03-06 2002-10-08 The General Hospital Corporation Photosensitizer conjugates for pathogen targeting
CA2298526A1 (en) * 1997-07-28 1999-02-04 Dermatolazer Technologies Ltd Phototherapy based method for treating pathogens and composition for effecting same

Also Published As

Publication number Publication date
CN1255063A (zh) 2000-05-31
JP2001513819A (ja) 2001-09-04
DE69835438T2 (de) 2007-03-15
CA2283868A1 (en) 1998-09-11
WO1998039011A1 (en) 1998-09-11
US6462070B1 (en) 2002-10-08
AU6676798A (en) 1998-09-22
EP1017397A1 (de) 2000-07-12
KR20000076016A (ko) 2000-12-26
US7268155B2 (en) 2007-09-11
CA2283868C (en) 2008-05-06
EP1017397A4 (de) 2004-06-16
AU737574B2 (en) 2001-08-23
DE69835438D1 (de) 2006-09-14
US20020183245A1 (en) 2002-12-05
EP1017397B1 (de) 2006-08-02

Similar Documents

Publication Publication Date Title
ATE334676T1 (de) Photo-empfindlichkeit-erhöhende conjugate zur targeting von pathogene
CY1111832T1 (el) Φθαλοκυανινες ψευδαργυρου και τα αντιστοιχα συζυγη, η παρασκευη αυτων και η χρηση στην φωτοδυναμικη θεραπεια και ως διαγνωστικοι παραγοντες
ATE316982T1 (de) Mehrere zytokin-antikörper komplexen
AU1312502A (en) Fluorescent nucleobase conjugates having anionic linkers
DK0909183T3 (da) DHA-konjugerede farmaceutisk midler
DE69925830D1 (de) Peg-lhrh analog konjugate
EA200400067A1 (ru) Конъюгаты гксф
BR9806784A (pt) Modificações do 2-amino-4-(4-fluorobenzilamino)-1-etoxicarbonilamin obenzeno, bem como processo para a sua preparação
DK0841949T3 (da) Anvendelse af saccharid-konjugater
BR0113162A (pt) Ariloxialquilaminas nao-imidazóis
BR9609229A (pt) Vacinas conjugadas de polissacarídeos meningocócitos modificados
DK1237584T3 (da) Receptorbindende konjugater
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
EP2962699A3 (de) Verbessertes verfahren zur herstellung von konjugaten von proteinen und chelatbildnern
ATE304709T1 (de) Substanzen mit verzweigten linkermolekülen
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
BR0110577A (pt) Decorina transgenicamente produzida
DK0557199T3 (da) Polyethylenglycol-hirudin-konjugater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af tromboser
DK0877631T3 (da) Konjugat af albumin og et xanthen-farvestof til differentiering mellem sygdomsramt og sundt væv
AU2002360350A1 (en) Peptides that home to tumor lymphatic vasculature and methods of using same
HN1998000102A (es) Composiciones solubilizadas de sertralina
HK1067492A1 (en) Method of making a homogenous doxorubicin-transferrin conjugate
NO943847L (no) Fremgangsmåte for fremstilling av makrocykliske chelateringsmidler og dannelse av chelater og konjugater derav
ES2145978T3 (es) Intermedios y su uso para preparar bisindolilmaleimidas con un puente n,n'.
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties